GSK may sell Horlicks to focus on OTC and oral health

Home › GSK may sell Horlicks to focus on OTC and oral health

The pharmaceuticals firm will take control of Sensodyne and Panadol from joint venture partner Novartis.

14.11	UK must rebuild post-Brexit relations with EU, says Bank boss
14.11	Meta fined 798m over 'unfair' Facebook Marketplace
14.11	Meta fined 798m over 'unfair' Facebook Marketplace
14.11	Amazon launches Temu and Shein rival with 'crazy low' prices
14.11	Bid to soften farm tax change rejected by Treasury
14.11	Baby milk prices 'punish those who don't breastfeed'
14.11	Why Canada could become the next nuclear energy 'superpower'
14.11	Apple accused of trapping and ripping off 40m iCloud customers
Consumer Goods and Services »

je.st